• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

細胞内標的化スマートナノDDSを用いた効率的かつ安全ながんワクチンの開発

Research Project

Project/Area Number 17F17035
Research Category

Grant-in-Aid for JSPS Fellows

Allocation TypeSingle-year Grants
Section外国
Research Field Nanomaterials chemistry
Research InstitutionKawasaki Institute of Industrial Promotion Innovation Center of NanoMedicine

Principal Investigator

Quader Sabina  公益財団法人川崎市産業振興財団(ナノ医療イノベーションセンター), ナノ医療イノベーションセンター, 主任研究員 (90749699)

Co-Investigator(Kenkyū-buntansha) MAITY AMIT  公益財団法人川崎市産業振興財団(ナノ医療イノベーションセンター), ナノ医療イノベーションセンター, 外国人特別研究員
Project Period (FY) 2017-04-26 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥2,300,000 (Direct Cost: ¥2,300,000)
Fiscal Year 2018: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 2017: ¥1,200,000 (Direct Cost: ¥1,200,000)
KeywordsPolymer Micelle / Epirubicin / Ligand / pH sensitive / Glucose Transporter 1 / Glioblastoma
Outline of Annual Research Achievements

We synthesized glucose decorated and epirubicin conjugated polymeric micelles that have pH-sensitive release profile. Epirubicin micelles had small size and uniform size distribution. We prepared epirubicin micelle decorated with different amount of glucose ( 0%, 25%, 50%, and 100%). The surface decoration of micelles by glucose molecule significantly affected their endocytosis, and fate in the cytoplasm. Specifically, glucose conjugated micelles are accompanied by exocytosis mechanism in parallel to endocytosis under monolayer cell culture condition with GLUT-1 overexpressed cell. Furthermore, under 3D multicellular tumor spheroid condition, this exocytosis mechanism of glucose micelles helps to drive the glucose micelles to penetrate deeper into tumor spheroid following transcytosis. And we observed, glucose epirubicin micelles having higher penetration than control micelles (that is 0% glucose decorated micelle). We confirmed that the epirubicin micelles with different amount of glucose decoration have long blood circulation property, which is one of the prerequisites for its therapeutic activities. We performed tumor accumulation and antitumor activity in an orthotopic breast cancer model. This tumor model had been selected as a pilot-study due to the fact that MDA-MB-231 cells overexpress GLUT1. We found significant difference between free epirubicin and epirubicin micelle groups. But no difference between the micelle groups was observed. Antitumor activity study against Glioblastoma models is currently undergoing.

Research Progress Status

平成30年度が最終年度であるため、記入しない。

Strategy for Future Research Activity

平成30年度が最終年度であるため、記入しない。

Report

(2 results)
  • 2018 Annual Research Report
  • 2017 Annual Research Report
  • Research Products

    (7 results)

All 2019 2018

All Presentation (6 results) (of which Int'l Joint Research: 6 results) Patent(Industrial Property Rights) (1 results) (of which Overseas: 1 results)

  • [Presentation] Delivering positively charged anticancer peptide drug using crosslinked and pH responsive nanomedicine2019

    • Author(s)
      Amit Ranjan Maity, Sabina Quader, Shigeto Osawa, Kazunori Kataoka
    • Organizer
      Sixth International Conference on Multifunctional, Hybrid and Nanomaterials
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Nanomedicine to Target Glioblastoma2018

    • Author(s)
      Sabina Quader, Xueying Liu, Horacio Cabral, Yu-Lin Su, Amit Ranjan Maity, Hiroaki Kinoh, Kazunori Kataoka
    • Organizer
      The 77th Annual Meeting of Japanese Cancer Association
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Nanomachine to deliver positively charged anticancer peptidic drug using crosslinked and pH responsive platform2018

    • Author(s)
      Amit Ranjan Maity, Sabina Quader, Shigeto Osawa, Kazunori Kataoka
    • Organizer
      The 77th Annual Meeting of Japanese Cancer Association
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Delivering Melittin using Crosslinked and pH responsive Nanomedicine2018

    • Author(s)
      Amit Ranjan Maity, Sabina Quader, Shigeto Osawa, Kazunori Kataoka
    • Organizer
      IPC 2018, The 12th SPSJ International Polymer Conference
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Delivering positively charged peptide/drug using crosslinked and pH responsive micelles2018

    • Author(s)
      Amit Ranjan Maity, Sabina Quader, Shigeto Osawa, Kazunori Kataoka
    • Organizer
      67th SPSJ annual meeting
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Delivering positively charged peptide/drug using crosslinked and pH responsive nanomachine2018

    • Author(s)
      Amit Ranjan Maity,Sabina Quader,Shigehito Osawa,Kazunori Kataoka
    • Organizer
      67th The Society of Polymer Science of Japan (SPSJ) Conference
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research
  • [Patent(Industrial Property Rights)] 脳腫瘍治療薬2019

    • Inventor(s)
      喜納,片岡,SQuader,持田,劉,ARMaity,福島
    • Industrial Property Rights Holder
      川崎市産業振興財団
    • Industrial Property Rights Type
      特許
    • Filing Date
      2019
    • Related Report
      2018 Annual Research Report
    • Overseas

URL: 

Published: 2017-05-25   Modified: 2024-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi